Challenges in optimizing preexposure prophylaxis development, engagement, and access for HIV prevention
Eileen P. Scully, … , Ethel D. Weld, Joel N. Blankson
Eileen P. Scully, … , Ethel D. Weld, Joel N. Blankson
Published December 2, 2019; First published November 11, 2019
Citation Information: J Clin Invest. 2019;129(12):5071-5073. https://doi.org/10.1172/JCI134389.
View: Text | PDF
Viewpoint

Figure 1

HIV infection risk and PrEP prescriptions in the United States.

Options: View larger image (or click on image) Download as PowerPoint
HIV infection risk and PrEP prescriptions in the United States. (A) Esti...
(A) Estimated proportions of people living in the United States at risk for HIV infection (2015 data) and distribution of PrEP prescriptions in 2016 among the subset for whom race/ethnicity data is available. (B) Risk versus prescription frequency among men and women (2015 data). Figure based on data in refs. 19, 21.